Clinical Research Directory

Inclusion Criteria: * Women of age 18-45 with signs of endometriosis on ultrasound and/or MRI and/or confirmed by laparoscopy with histology at Akershus University Hospital and Oslo University Hospital. Women may also be recruited through social media but must present with diagnosis of endometriosis. * genital-pelvic pain ≥4/10 as measured on a numeric rating scale. * able to understand and speak Norwegian language * able to meet at Akershus University Hospital for participation in the study * giving signed consent to participate. Exclusion Criteria: * Intra-abdominal or vaginal surgery in the last six months * Patients who have received Botox over the past four months * Severe pathology (malignancy),cardiovascular conditions and immune system diseases diagnosed by specialist; pregnancy, as well as childbirth the last 12 months and breastfeeding; severe psychiatric disorders that demands or has demanded admission to the hospital; personality disorder diagnosed by specialist and recently started or recently adjusted ongoing hormonal therapy. * Participants should not have any disease or injury that could prevent them from participating in the intervention. * Participants will be encouraged not to start with any new treatment (non-pharmacological or pharmacological) during the four-month intervention period. * Participants who have recently undergone surgery and received Botox injections into the pelvic area can be referred but must wait 4-6 months before being included in the study. Women with planned surgery or Botox in the study period will be excluded. * Participants recently started or adjusting ongoing hormonal therapy must wait 3-6 months to be included in the study.